Trials / Completed
CompletedNCT03768180
Infective Endocarditis After TAVR
INfecTive ENdocarditis After Transcatheter Aortic Valve Replacement (TAVR) a National SwEdish Study (INTENSE)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,600 (actual)
- Sponsor
- Region Skane · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study aims at studying the frequency of infective endocarditis after transcatheter aortic valve replacement/implantation
Detailed description
Since the start of transcatheter aortic valve implnatations/replacements (TAVR/TAVI) implantations in Sweden in 2008 all procedures have been added to a national database, which now contains 4500+ procedures. At the same time, all admissions to the hospital is also recorded with diagnosis in a separate database. We intend to make a nation-wide complete follow up of all TAVR/TAVI patients in swede that has received the diagnosis of infective endocarditis after the implantation. In addition data will also be collected from the national endocarditis database for detailed information of the cases.
Conditions
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2019-08-01
- Completion
- 2019-08-01
- First posted
- 2018-12-07
- Last updated
- 2020-04-06
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT03768180. Inclusion in this directory is not an endorsement.